Department of Health Outcomes Research & Policy, Harrison School of Pharmacy, Auburn University, Auburn, AL.
J Manag Care Spec Pharm. 2021 Sep;27(9-a Suppl):S12-S16. doi: 10.18553/jmcp.2021.27.9-a.s12.
Cost-effectiveness analysis (CEA) with quality-adjusted life-year (QALY) was introduced to address health equity concerns in value assessment. However, QALY fails to capture patient preference. Stated preference methods (eg, discrete choice experiment [DCE]) have been increasingly used to incorporate patient preference into the value assessment framework in health care. Still, ones with a moral dimension such as health equity do not exist. The objective of this paper was to describe 2 stated preference approaches that can empirically value health equity. First, the decision-maker perceptions of the prevalence of equity dimensions in DCE choice tasks are identified. A latent class model based on random utility theory is proposed to derive the value of equity from the decision makers with different perceptions of the prevalence of equity dimensions. Second, equity attributes are incorporated in DCE choice tasks, and a quantum choice model, which can capture stochasticity during the decision process in the mind of the decision makers, is used to value the equity. These approaches will improve existing value assessment methods to address health equity adequately. This study received no outside funding. Ngorsuraches has received research grants from Bristol Myers Squibb and through the University of Utah and PhRMA Foundation.
成本效益分析(CEA)与质量调整生命年(QALY)的结合,旨在解决价值评估中公平性问题。然而,QALY 无法捕捉患者的偏好。因此,越来越多的选择偏好方法(如离散选择实验 [DCE])被用于将患者偏好纳入医疗保健的价值评估框架。然而,对于具有道德维度的问题(如公平性),目前还没有选择偏好方法。本文的目的是描述两种可以从经验上评估公平性的选择偏好方法。首先,确定决策者在 DCE 选择任务中对公平性维度的普遍程度的看法。基于随机效用理论的潜在类别模型被提出,以从对公平性维度的普遍程度有不同看法的决策者中得出公平性的价值。其次,将公平性属性纳入 DCE 选择任务中,并使用量子选择模型,该模型可以捕捉决策者思维中决策过程中的随机性,以评估公平性。这些方法将改进现有的价值评估方法,以充分解决公平性问题。本研究没有获得外部资金。Ngorsuraches 从 Bristol Myers Squibb 获得了研究资助,并通过犹他大学和 PhRMA 基金会获得了资助。